Association of the Pro12Ala gene polymorphism with treatment response to thiazolidinediones in patients with type 2 diabetes: a meta-analysis-Reference-Cited by-同舟云学术

Association of the Pro12Ala gene polymorphism with treatment response to thiazolidinediones in patients with type 2 diabetes: a meta-analysis

Published:2022-05-31 Issue:3 Volume:42 Page:412-419
ISSN:0973-3930
Container-title:International Journal of Diabetes in Developing Countries
language:en
Short-container-title:Int J Diabetes Dev Ctries

Author:

Vallo Johana,Arbas Roselle,Basilio Jan Erika,Cayabyab Ivy,Miranda Christian Noel,Santos Ma. Paulina Isabel,Legaspi Louie Fernand,Tiongco Raphael Enrique

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13410-022-01086-z.pdf

Reference36 articles.

1. Nanjan MJ, Mohammed M, Prashantha Kumar BR, Chandrasekar MJN. Thiazolidinediones as antidiabetic agents: a critical review. Bioorg Chem. 2018;77:548–67.

2. Hauner H. The mode of action of thiazolidinediones. Diabetes Metab Res Rev. 2002;18:S10–5.

3. Jia C, Huan Y, Liu S, Hou S, Sun S, Li C, Liu Q, Jiang Q, Wang Y, Shen Z. Effect of chronic pioglitazone treatment on hepatic gene expression profile in obese C57BL/6J mice. Int J Mol Sci. 2015;16:12213–29.

4. Smith U. Pioglitazone: mechanism of action. Int J Clin Pract Suppl. 2001.

5. Tyagi S, Gupta P, Saini A, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2:236–40.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling clinically significant PPARγ mutations for thiazolidinedione treatment responsiveness through atomistic simulations;International Journal of Biological Macromolecules;2023-12

2. Correlation between PPARG Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis;Pharmaceutics;2023-06-20

3. Natural products targeting inflammation-related metabolic disorders: A comprehensive review;Heliyon;2023-06

4. Correction to: Association of the Pro12Ala gene polymorphism with treatment response to thiazolidinediones in patients with type 2 diabetes: a meta-analysis;International Journal of Diabetes in Developing Countries;2022-06-13